News

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended beneficial ownership statement with the SEC on November 12, 2026, disclosing a combined holding of 672,616 shares of Aldeyra Therapeutics, Inc. common stock as of September 30, 2026.

James Barry, Executive Vice President and President of the Life Science Group at Bio-Rad Laboratories, Inc., filed a statement of changes in beneficial ownership on November 10, 2026, reporting the sale of Bio-Rad Class A Common Stock on November 9, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed Amendment No. 3 to Schedule 13G with the SEC on November 12, 2026, disclosing a combined beneficial ownership position in BellRing Brands, Inc. common stock as of September 30, 2026.

JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 12, 2026, disclosing the terms of 6-year S&P 500 Futures Excess Return Index-linked uncapped dual directional accelerated barrier notes with a pricing date of November 24, 2026, and a maturity date …

Barrow Hanley Mewhinney & Strauss LLC filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of 6,337,899 shares of Warner Music Group Corp. common stock, representing 4.29% of the class, as of September 30, 2026.

Gina M. Goetter, Executive Vice President and Chief Financial Officer of Hasbro, Inc., filed a Form 4 on November 12, 2026, reporting the sale of 2,840 shares of Hasbro common stock on November 10, 2026, pursuant to a Rule 10b5-1 trading plan.

Director Veronique Morali filed a Form 4 with the SEC on November 11, 2026, reporting two transactions in Amdocs Ltd ordinary shares on November 9 and November 10, 2026.